The development of monosomy 19 mouse embryos

Area of Science:

• Developmental Biology
• Genetics
• Mammalian Embryogenesis

Background:

• Autosomal monosomy is typically lethal earlier in mammalian development than autosomal trisomy.
• Understanding the causes of monosomy lethality is crucial for developmental biology.
• Chromosome 19 monosomy in mice provides a model to study early developmental failure.

Purpose of the Study:

• To investigate the reasons behind the lethality of mouse embryos with monosomy for chromosome 19.
• To determine if monosomy 19 is cell-lethal or due to dosage-sensitive gene products.
• To characterize the developmental timing and cellular basis of monosomy 19 lethality.

Main Methods:

• Developmental assessment of mouse embryos monosomic for chromosome 19 in vivo and in vitro.
• Cell counting and blastocyst formation assays.
• Electron microscopy for ultrastructural analysis.
• Two-dimensional gel electrophoresis for protein synthesis comparison.
• Chimeric embryo studies with monosomic and diploid cells.

Main Results:

• A dramatic loss of monosomy 19 embryos occurs between days 3 and 4 of development.
• Monosomic embryos have fewer cells but can still form blastocysts.
• No differences in cellular ultrastructure or protein synthesis were observed between monosomic, trisomic, and diploid embryos.
• Monosomic cells were viable in chimeras past the typical lethal period.

Conclusions:

• Monosomy 19 is not cell-lethal, as evidenced by viability in chimeras.
• The lethality of monosomy 19 embryos is likely due to altered dosage of specific gene products required during early development.
• Further research is needed to identify the specific dosage-sensitive genes involved in early mouse embryogenesis.